Related Experiment Video
Updated: Jun 5, 2026
07:44
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Pediatric meningioma: current approaches and future direction
Rishi S Kotecha1, Reimar C Junckerstorff, Sharon Lee
1Department of Hematology and Oncology, Princess Margaret Hospital for Children, GPO Box D184, Perth, WA 6840, Australia. rishi_k28@hotmail.com
Journal of Neuro-Oncology
|January 5, 2011
Summary
Pediatric meningiomas are rare brain tumors. This review highlights current knowledge and future research directions for treating these childhood central nervous system (CNS) tumors, emphasizing unique biology and quality of life.
Area of Science:
- Pediatric neuro-oncology
- Childhood cancer research
- Central nervous system (CNS) tumor biology
Background:
- Central nervous system (CNS) tumors are the leading cause of cancer mortality in children.
- Meningiomas are rare intracranial tumors in pediatric patients, originating from meninges.
- Lack of prospective trials necessitates reliance on retrospective data and adult meningioma treatment extrapolation.
Purpose of the Study:
- To review current knowledge on pediatric meningiomas.
- To identify research gaps and future directions for pediatric meningioma management.
- To address the unique biological and quality of life considerations in treating childhood brain tumors.
Main Methods:
- Literature review of pediatric meningioma cases.
- Analysis of retrospective data on meningioma treatment in children and adolescents.
- Comparison of adult and pediatric meningioma biology.
Main Results:
- Pediatric meningiomas exhibit distinct biology compared to adult counterparts.
- Current management strategies are often extrapolated from adult data due to rarity.
- Long-term quality of life is a critical factor in pediatric brain tumor treatment.
Conclusions:
- Further research is needed to understand the unique biology of pediatric meningiomas.
- Development of specific therapeutic strategies for pediatric meningiomas is crucial.
- Collaborative prospective trials are essential for advancing treatment and improving outcomes for children with meningiomas.
